Gene Logic Shares Slide Nearly 15 Percent on News of Goodwill Asset Impairment | GenomeWeb

NEW YORK, Sept. 23 (GenomeWeb News) - Shares of Gene Logic's are down 14.8 percent, or $.83, at $4.82 in afternoon trading following news yesterday that the value of the goodwill asset from its 2003 acquisition of TherImmune Research is impaired.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.